Related Experiment Video

Updated: Jul 6, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Utilization of genomic signatures to direct use of primary chemotherapy

Anil Potti1, Joseph R Nevins

  • 1Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27708, United States.

Current Opinion in Genetics & Development
|March 15, 2008
PubMed

Insights

Genomic analysis, specifically gene expression profiling, helps personalize cancer treatment by identifying distinct molecular mechanisms within tumors. This approach matches effective therapies to individual patients, improving outcomes and managing risks.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Cancer treatment success relies on matching therapies to individual patient and tumor characteristics.
  • Tumor heterogeneity presents a major challenge, as cancers like breast, lung, and colon are diverse molecular disorders, not single diseases.

Purpose of the Study:

  • To review the development and success of gene expression signatures for predicting cancer therapeutic response.
  • To discuss the challenges and opportunities of implementing these genomic tools in clinical practice.

Main Methods:

  • Review of studies on gene expression profiling in cancer.
  • Analysis of the predictive capacity of gene expression signatures for various cancer therapeutics.

Main Results:

  • Gene expression profiling can dissect tumor heterogeneity, revealing distinct molecular mechanisms.
  • Developed gene expression signatures show promise in predicting patient response to cancer therapies.

Conclusions:

  • Genomic analysis, particularly gene expression profiling, is crucial for personalized cancer medicine.
  • Utilizing gene expression signatures offers opportunities to optimize treatment selection and improve patient outcomes.

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Assessing Specificity of Anticancer Drugs In Vitro09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...